Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 37 most recent Form 4 transactions.
| May 8 | PTGX | Protagonist Therapeutics,… | SSELL | 5,130 | $100.00 | $513K | -28.8% | Open the original filing on SEC.gov |
| May 8 | PTGX | Protagonist Therapeutics,… | SSELL | 6,000 | $100.00 | $600K | -100.0% | Open the original filing on SEC.gov |
| May 7 | PTGX | Protagonist Therapeutics,… | MEXER◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| May 7 | PTGX | Protagonist Therapeutics,… | MEXER◆ | 24,000 | — | — | — | Open the original filing on SEC.gov |
| May 7 | PTGX | Protagonist Therapeutics,… | SSELL | 12,000 | $100.07 | $1.2M | -66.7% | Open the original filing on SEC.gov |
| May 7 | PTGX | Protagonist Therapeutics,… | SSELL | 36,000 | $100.14 | $3.6M | -56.4% | Open the original filing on SEC.gov |
| May 7 | PTGX | Protagonist Therapeutics,… | MEXER | 12,000 | $6.98 | $83.8K | +37.7% | Open the original filing on SEC.gov |
| May 7 | PTGX | Protagonist Therapeutics,… | MEXER | 24,000 | $6.45 | $154.8K | +306.7% | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 96,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 47,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 176,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 211,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 211,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 181,250 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 543,750 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 638,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 693,750 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 96,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 47,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 176,667 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 211,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 211,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 181,250 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 543,750 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 638,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 693,750 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 693,750 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | GOSS | Gossamer Bio, Inc. | AGRANT | 115,750 | — | — | +42.3% | Open the original filing on SEC.gov |
| Jan 2 | PTGX | Protagonist Therapeutics,… | AGRANT◆ | 3,762 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | PTGX | Protagonist Therapeutics,… | AGRANT | 2,695 | — | — | +17.8% | Open the original filing on SEC.gov |
| Oct 1, 2025 | GOSS | Gossamer Bio, Inc. | AGRANT | 181,250 | — | — | +195.4% | Open the original filing on SEC.gov |